11 Best Cosmetic Surgery and Aesthetics Stocks to Invest in Now

1. Johnson & Johnson (NYSE:JNJ)

Number of Hedge Fund Investors: 81      

The multinational healthcare firm Johnson & Johnson (NYSE:JNJ), through its subsidiary MENTOR, specializes in breast reconstruction and aesthetics. For use in cosmetic and reconstructive breast surgery treatments, the company offers breast implants, tissue expanders, and other surgical materials. Mentor’s Breast Implant Simulator app allows users to submit images or use real-time video to model implant sizes. It uses augmented reality to display breast augmentation outcomes. It also provides educational content, connects users to nearby surgeons, and makes it easier to share discoveries for feedback.

Revenue increased by 5.25% YoY to $22.47 billion in the third quarter of 2024, with Innovative Medicine leading the way with a 4.9% YoY growth to $14.58 billion. Moreover, the MedTech division, which encompasses aesthetics, reported a 6.4% increase in operational sales in the third quarter of 2024. Acquisitions such as Abiomed had a favorable effect on this division. The firm produced $14 billion in free cash flow in the first nine months of this year, compared to $11.9 billion in the same period last year.

For the past 62 years, Johnson & Johnson (NYSE:JNJ) has consistently increased its dividends. The current quarterly dividend paid by the firm is $1.62 per share.

An analyst at Wolfe Research named Alexandria Hammond began covering Johnson & Johnson (NYSE:JNJ) with a $190 price target and an Outperform rating. Beyond Mounjaro/Zepbound from Lilly (LLY), the firm anticipates growth names and/or “dream the dream” names to win in 2025. J&J’s Pharma growth drivers, including JNJ-2113, Tremfya, nipocalimab, Carvykti, and Drazalex Faspro, are viewed as “best-in-class” by the firm. Moreover, Wolfe predicts that J&J’s revenue would increase by at least 3% despite Stelara’s loss of exclusivity challenges.

Ken Fisher’s Fisher Asset Management was the largest stakeholder in the company from among the funds in Insider Monkey’s database. It owns 7,560,199 shares worth $1.23 billion as of Q3.

Overall, Johnson & Johnson (NYSE:JNJ) ranks first on our list of the Best Cosmetic Surgery and Aesthetics Stocks to Invest in Now. While we acknowledge the potential for JNJ to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter timeframe. If you are looking for an AI stock that is more promising than JNJ but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.

READ NEXT:  8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock.

Disclosure: None. 11 Best Cosmetic Surgery and Aesthetics Stocks to Invest in Now is originally published on Insider Monkey. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.